most effective glp-1 for obesity treatment 2025 What is the pipeline future medications for obesity? The future of GLP-1s: Cost,

Ongoing care is important to be sure your weight loss is healthy and sustainable, to monitor for optimal nutritional intake, and to be able to quickly course correct if any adverse effects are identified, says Bonilla

the most commonly reported adverse events in trials were gastrointestinal, including nausea, vomiting, and diarrhoea

The early decline phase (weeks 2-8) marks when users first notice subtle changes as copper levels normalize to dietary intake baseline, collagen synthesis rates decline toward pre-treatment levels, and the balance between new collagen production and ongoing degradation shifts toward net neutral or slight decline

by Robert Kushner, MD Fall 2021 Disclaimer: Consult with your healthcare provider if you are interested in starting Wegovy